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Abstract Langerhans cell histiocytosis (LCH) is a rare
disease that can infiltrate various organs. LCH presents
with solitary organ involvement or as a multi-system dis-
ease. We present a patient who has tonsillary infiltration
with LCH. A 74 year-old Caucasian male was admitted for
swelling of the neck and difficulty swallowing for
3 months. Physical examination showed submandibular
lymph node enlargement of approximately 3 cm and tonsil
enlargement. A tonsillectomy and excisional biopsy of the
lymph node were done. Histiocyte-like cell infiltration was
seen in the tonsil biopsy. CD3, CD20, CD15, CD30, CD5,
CD138, Lambda, Kappa, Bcl-2, ALK, CD23, CD10, Bcl-6,
keratin, EMA, HMB-45, and Cyl D1 were negative. CD68,
S-100, CD1a, and fascin were positive, and the Ki-67
proliferation index was 20 % in immunocytochemical
staining. The most commonly infiltrated bones are the
skull, femur, lower jaw, pelvis, and vertebrae in LCH. Oral
or perioral lesions are present in 30 % of cases. Oral
lesions most often involve bone loss, unexpected tooth loss,
and gum inflammation. We administered oral prednisolone
to our patient due to the presence of lytic lesion of the
bone, mild anemia and a higher sedimentation rate, which
was from a separate, explained cause. Isolated tonsillar
involvement in adult LCH was reported in only 2 cases in
the literature. There is no standard recommendation for
treatment. Our patient responded well to steroid therapy.
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Introduction
Langerhans cell histiocytosis (LCH) is a rare disease that
can infiltrate various organs. LCH presents with solitary
organ involvement or as a multi-system disease. It usually
affects the bone, skin, and pituitary gland, and occasionally
affects the hematopoietic system, lymph nodes, and lungs
[1]. LCH is most often found in the pediatric population
and less commonly in adults [1]. In this paper, we present a
case report of an adult patient with tonsil infiltration with
LCH.
Case Presentation
In December 2013, a 74 year-old Caucasian male was
admitted to our hematology clinic for swelling of the neck
and difficulty swallowing for 3 months. He had no previ-
ous medical history and did not take medications. Physical
examination showed submandibular lymph node enlarge-
ment of approximately 3 cm and tonsil enlargement. A
tonsillectomy and excisional biopsy of the lymph node
were done. Histiocyte-like cell infiltration was seen in the
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tonsil biopsy. CD3, CD20, CD15, CD30, CD5, CD138,
Lambda, Kappa, Bcl-2, ALK, CD23, CD10, Bcl-6, keratin,
EMA, HMB-45, and Cyl D1 were negative. CD68, S-100,
CD1a, and fascin were positive, and the Ki-67 proliferation
index was 20 % in immunocytochemical staining (Fig. 1–
4). Reactive lymphocytic proliferation was seen in the
lymph node biopsy. For the patient’s risk stratification, we
conducted cervical-thoracal-abdominal computerized
tomography (CT) scanning, whole body positron emission
tomography (PET) PET CT, and a bone marrow biopsy.
F-18 fluorodeoxyglucose (FDG) uptake positive for lytic
lesion (standard uptake value (SUV) max: 9.59) was seen
in the subtrochanteric area of the left femur in PET CT.
There was no abnormal cell infiltration in the bone marrow
biopsy and no lymph node enlargement was found during
the thoraco-abdominal CT scanning. His laboratory values
were mild normochromic normocytic anemia with mild
higher sedimentation rate. We gave him oral prednisolone
at a dose of 1 mg/d for 6 week. Steroids were gradually
tapered off. Following this treatment schedule, he had no
complaints and his laboratory values were normal and FDG
uptake were not seen in the whole body PET CT.
Discussion
LCH was renamed by the Histiocyte Society in 1985. Its
former names were eosinophilic granuloma, histiocytosis
X, Letterer-Siwe disease, and Hand-Schuller-Christian
disease [2]. Although the etiology of the disease is not
Fig. 1, 2 Langerhans cell histiocytosis (LCH) in the tonsil. Low-power view shows sheets of tonsil LCH cells with grooved, folded nuclei; pale
eosinophilic cytoplasm; and interspersed eosinophils (Fig. 1; H ? E, X50) (Fig. 2; H ? E, X200)
Fig. 3 CD1a staining of the sinusoidal LCH cells are demonstrated
(immunoperoxidase, CD1a X200)
Fig. 4 LCH cells are cytoplasmic positive with fascin (immunoper-
oxidase, Fascin X200)
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known, it could be caused by an immunological dysregu-
lation subsequent to cytokine and prostaglandin over-pro-
duction [3].
The disease can be difficult to diagnose. Cases of LCH
exhibiting immature morphology and few associated
eosinophils should be excluded using appropriate markers
(S-100, CD1a, and langerin) [4]. The immuno-histochem-
ical staining feature in our patient’s biopsy material sup-
ported the exact diagnosis. LCH is typically a systemic
infiltrating disease and can present in 2 forms; non-sys-
temic (localized) disease and systemic (multi-focal) dis-
ease. The distribution of affected organs shapes the
prognosis of the disease [5]. The frequency of involvement
of the bone is 80 %; skin, 25 %; the pituitary gland, 25 %;
spleen, 15 %; liver, 15 %; the hematopoietic system, 15 %;
lymph nodes, 5–10 %; and cranial involvement excluding
the pituitary gland, 2–4 % [1]. The most commonly infil-
trated bones are the skull, femur, lower jaw, pelvis, and
vertebrae [6]. Oral or perioral lesions are present in 30 %
of cases [6]. Oral lesions most often involve bone loss,
unexpected tooth loss, and gum inflammation [6]. Isolated
infiltration of the tonsil is rare; only 2 case reports were
found in the literature review [7, 8].
The first case was reported by Issing et al. The patient
was not given medication and remained in remission for
16 months [7]. Hwang et al. reported the case of a 68 year-
old man with tonsil enlargement due to the infiltration of
LCH concomitantly with acute myeloblastic leukemia. The
lymph node enlargement resolved spontaneously with
acute leukemia treatment. The authors explained that this
unusual case, involving neoplastic histiocytic cells and
leukemic cells could have been a member of the same
clone or a reaction to the acute leukemia [8]. Treatment
recommendations were completed according to the pre-
sentation of the disease. In some cases, localized surgical
excisional biopsy may be sufficient for treatment, while
other cases require the application of multi-agent chemo-
therapy protocols [9]. Our patient had infiltration of uni-
lateral tonsil, only one lytic lesion of the bone and mild
anemia without bone marrow infiltration. We did not find
any author advice regarding isolated infiltration of the
lymph nodes and tonsils. In these cases, the watch and wait
method should be considered because of the potential for
spontaneous regression [10]. We administered oral
prednisolone to our patient due to the presence of lytic
lesion of the bone, mild anemia and a higher sedimentation
rate, which was from a separate, explained cause.
Conclusion
Isolated tonsillar involvement in adult LCH was reported in
only 2 cases in the literature. There is no standard rec-
ommendation for treatment. Our patient responded well to
steroid therapy.
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